ArticleBMC genomics2026
DGM: deep graph clustering with mincut for analysis of single-cell transcriptomics.
Article in BMC genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveSingle-cell RNA sequencing (scRNA-seq) is pivotal for deciphering cellular heterogeneity in biomedical research, from developmental biology to cancer studies. However, accurate cell type identification via clustering remains challenging. Current graph-based methods are limited by ignoring higher-order topologies.
methodsWe present Deep Graph MinCut (DGM), an end-to-end deep learning framework designed to overcome these limitations. Its core innovation is the joint optimization of three objectives: (1) a higher-order MinCut loss for capturing complex cellular communities; (2) an inter-cluster orthogonality loss to enforce clear separation between cell populations; and (3) a reconstruction constraint to maintain global graph structure.The model jointly optimizes autoencoder denoising, graph learning, and cluster assignment.
resultsEvaluated on ten public scRNA-seq datasets, DGM achieved average improvements of 2.03% in NMI and 3.11% in ARI, outperforming baseline methods. Crucially, downstream biological analysis demonstrated alignment with known marker genes and developmental trajectories, verifying its ability to produce biologically meaningful and interpretable clusters.
conclusionDGM provides a robust and biologically interpretable framework for cell type identification, with potential for applications in cancer research and developmental biology. By addressing key computational challenges, DGM generates reliable outcomes that may contribute to downstream research, such as biomarker discovery or characterization of tumor microenvironment heterogeneity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.